Archit Organosys logo

Archit Organosys

ARCHITORGANOSYSLTD NSE

Key Fundamentals

MicrocapCommodity ChemicalsChemicals
Market Cap
₹137 Cr
Volatility
Moderate
P/E Ratio
18
EBITDA
₹9.20 Cr
Return on Equity
5.11%
Debt to Equity
0.32
Book Value
₹37.15
EPS
₹0.36
52W High
₹67
52W Low
₹34

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Weaknesses

2
  • The company has delivered a poor sales growth of 8.32% over past five years.
  • Company has a low return on equity of 6.71% over last 3 years.

Growth Rate

Revenue Growth
-10.8% lower than 3Y
Net Income Growth
-70.8% lower than 3Y
Cash Flow Change
-41.42% higher than 3Y
ROE
-72.18%
ROCE
-58.31%
EBITDA Margin (Avg.)
-50.31%

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
31
26.39
24.81
30.99
27
29.54
25.87
43.18
33.2
32.86
38.4
36.5
37.08
Expenses
27.76
24.28
23.71
30.7
23.95
26.69
23.21
38.76
29.06
30.16
33.72
31.61
33.71
Operating Profit
3.24
2.11
1.1
0.29
3.05
2.85
2.66
4.42
4.14
2.7
4.68
4.89
3.37
OPM %
10.45%
8%
4.43%
0.94%
11.3%
9.65%
10.28%
10.24%
12.47%
8.22%
12.19%
13.4%
9.09%
Other Income
0.71
0.54
0.52
4.11
0.47
0.63
0.93
1.06
1
1.46
0.9
-0.47
0.6
Interest
0.52
0.65
0.77
0.64
0.62
0.78
0.47
0.71
0.6
0.67
0.56
0.46
0.44
Depreciation
1.19
1.49
1.49
1.48
1.49
1.5
1.49
1.46
1.49
1.52
1.52
1.49
1.5
PBT
2.24
0.51
-0.64
2.28
1.41
1.2
1.63
3.31
3.05
1.97
3.5
2.47
2.03
Tax %
26.79%
27.45%
-29.69%
21.49%
29.08%
15%
37.42%
38.67%
33.11%
21.83%
30.86%
18.22%
28.57%
Net Profit
1.64
0.37
-0.46
1.79
1.01
1.02
1.01
2.02
2.04
1.54
2.43
2.02
1.45
EPS in Rs
0.8
0.18
-0.22
0.87
0.49
0.5
0.49
0.98
0.99
0.75
1.18
0.98
0.71
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
56
51
48
82
84
77
95
138
128
113
126
141
145
Expenses
53
48
44
78
87
73
83
121
108
106
113
125
129
Operating Profit
2
3
4
4
-3
4
11
17
20
7
13
16
16
OPM %
4%
6%
8%
4.6%
-3.6%
4.6%
12%
12%
15%
6%
10%
12%
11%
Other Income
1
1
0
3
3
2
0
1
3
6
3
3
2
Interest
1
1
1
4
4
3
3
2
2
3
3
2
2
Depreciation
0
0
1
3
3
3
4
5
5
6
6
6
6
PBT
1
2
3
0
-6
-1
5
11
15
4
8
11
10
Tax %
43%
37%
42%
-32%
-25%
1%
-7%
28%
26%
24%
33%
27%
—
Net Profit
1
1
2
1
-5
-1
5
8
11
3
5
8
7
EPS in Rs
0.87
0.97
1.14
0.34
-3.14
-0.53
3.34
4.01
5.57
1.63
2.46
3.91
3.62
Div. Payout %
0%
0%
0%
0%
0%
0%
15%
19%
9%
0%
0%
26%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
3
5
10
15
15
15
15
21
21
21
21
21
Reserves
2
8
17
25
20
19
26
31
41
44
49
56
Borrowings
9
11
31
36
37
33
30
34
31
26
28
25
Other Liabilities
10
8
12
26
12
16
17
18
27
18
26
25
Total Liabilities
24
32
70
101
84
83
87
104
120
108
123
127
Fixed Assets
6
6
47
47
47
50
48
45
50
60
54
50
CWIP
0
8
1
8
5
1
3
13
14
1
1
0
Investments
0
0
0
0
0
0
0
1
4
6
6
7
Other Assets
18
18
22
46
32
32
37
44
52
42
62
70
Total Assets
24
32
70
101
84
83
87
104
120
108
123
127
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
2
1
2
-4
3
8
11
11
18
10
19
3
Investing
-2
-8
-35
-9
1
-1
-3
-12
-12
-2
-21
4
Financing
1
7
32
13
0
-9
-7
2
-7
-9
-1
-6
Net Cash Flow
0
0
0
0
4
-2
1
2
0
-1
-4
1
Free Cash Flow
0
-7
-32
-13
3
6
8
0
9
15
18
1
CFO/OP
93
57
75
-90
-97
221
99
71
108
164
150
30
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
76
79
86
140
62
94
97
72
107
72
67
64
Inventory Days
28
28
27
41
30
22
21
22
16
16
18
11
Days Payable
72
63
80
126
55
88
87
51
110
62
94
65
Cash Conversion Cycle
33
44
33
56
38
28
30
44
13
26
-8
10
Working Capital Days
-1
3
19
12
-23
-39
-15
0
10
10
45
40
ROCE %
20%
17%
9%
6%
-4%
3%
12%
18%
17%
4%
11%
13%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Archit Organosys insights

58 extracted metrics + investor summaries across FY10–FY26.

Log in — free

Shareholding Pattern

Promot.65.88%Others4.30%Public29.82%As ofJun 2026

Documents

1
Concall - Nov 2025 Nov 2025
2
Concall - Aug 2025 Aug 2025
3
Concall - May 2025 May 2025
4
Concall - Feb 2025 Feb 2025
5
Concall - Nov 2024 Nov 2024

Frequently Asked Questions about Archit Organosys

What does Archit Organosys Ltd do?
Incorporated in 1989, Archit Organosys Ltd does manufacturing and trading of chemicals and organics[1]
Where is Archit Organosys Ltd (524640) listed?
Archit Organosys Ltd trades as ARCHITORGANOSYSLTD on the NSE and under code 524640 on the BSE.
Which sector does Archit Organosys Ltd belong to?
Archit Organosys Ltd is classified under the Chemicals sector, in the Commodity Chemicals industry.
What is the market capitalisation of Archit Organosys Ltd?
Archit Organosys Ltd has a market capitalisation of ₹137.23 Cr, which places it in the Small Cap band.
What is the PE ratio of Archit Organosys Ltd?
Archit Organosys Ltd trades at a PE ratio of 18.00, on earnings per share of ₹0.36, against a book value of ₹37.15 per share.
What is the 52-week high and low of Archit Organosys Ltd?
Over the last 52 weeks Archit Organosys Ltd has traded between ₹34 and ₹67.
Does Archit Organosys Ltd pay dividends?
Archit Organosys Ltd has a dividend yield of 1.53%.
What is the Return on Equity (ROE) of Archit Organosys Ltd?
Archit Organosys Ltd reported a return on equity of 5.11%. Its debt-to-equity ratio is 0.32.

Company Information

Incorporated in 1989, Archit Organosys Ltd does manufacturing and trading of chemicals and organics[1]

Website architorg.com
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524640.md for Archit Organosys Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Chemicals → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List